Results 181 to 190 of about 142,317 (291)
Myositis specific autoantibodies – What is the clinical usefullness?
Bernadett Hídvégi +5 more
openalex +1 more source
Objective: Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by joint pain, swelling, and stiffness. While smoking is a well‐established risk factor for RA, the role of occupational inhalants in RA development is less well recognized.
Qianwen Liu +7 more
wiley +1 more source
Gender and ethnicity differences in the prevalence of scleroderma-related autoantibodies
Malgorzata E Krzyszczak +8 more
openalex +2 more sources
Prothrombotic Activation of Platelet Pannexin 1 Channels in Antiphospholipid Syndrome
Background ATP is released from platelets through both degranulation and pannexin‐1 (PANX1) channels. ATP then activates P2X receptors to amplify platelet activation via calcium‐dependent signaling. Objective To evaluate the role of platelet PANX1 channels in the pathophysiology of antiphospholipid syndrome (APS), an acquired thrombo‐inflammatory ...
Bruna de Moraes Mazetto Fonseca +13 more
wiley +1 more source
Fusion of CT radiomics and autoantibody biomarkers for enhanced prediction of lung cancer diagnosis: a comprehensive study. [PDF]
Xia X +10 more
europepmc +1 more source
Effect of early initation of Eculizumab in patients with aHUS on renal outcomes: a pooled analysis [PDF]
Ardissimo, Gianluigi +5 more
core
Nanomaterial‐based immune therapeutic strategies in neurodegenerative diseases
This review highlights the immunomodulatory potential of nanomaterials (NMs) in treating neurodegenerative diseases (NDs). It focuses on their roles in regulating innate and adaptive immune responses to maintain immune homeostasis. By providing insights into these mechanisms, the review lays the groundwork for innovative NMs therapeutic strategies to ...
Xinru Zhou +6 more
wiley +1 more source
Tumor-Associated Autoantibodies Anti-p53 is Associated with Poor Prognosis in Patients with Lung Adenocarcinoma. [PDF]
Jing K +5 more
europepmc +1 more source

